Nordic EMBL Partnership for Molecular Medicine

The Nordic EMBL Partnership for Molecular Medicine is a large-scale research infrastructure that was established in 2007 as a joint venture (2008-2012) between the European Molecular Biology Laboratory (EMBL) and the Universities of Helsinki (Finland), Oslo (Norway) and Umeå (Sweden), co-funded by Nordforsk under the Network of Centres of Excellence programme, and involved building of national sister institutions in the three countries serving as large-scale research infrastructures.

The partnership between EMBL, the Institute for Molecular Medicine Finland (FIMM, www.fimm.fi), the Centre for Molecular Medicine Norway (NCMM, http://www.ncmm.uio.no) and the Laboratory for Molecular Infection Medicine Sweden (MIMS, www.mims.umu.se) is dedicated to the growing field of Life Sciences that investigates the molecular basis of disease and explores molecular and genetically based treatments. In 2012, a donation from the Lundbeck foundation allowed the establishment of a Danish Centre in Neuroscience and Molecular Medicine at Aarhus University. The Danish Research Institute of Translational Neuroscience (DANDRITE, http://dandrite.au.dk/) joined the partnership when a new partnership agreement with the EMBL was signed for 2013-2022 in Aarhus in March 2013.

Aiming to combine complementary strengths in the Nordic EMBL Partnership each partner brings in a unique set of expertise, skills and facilities encompassing EMBL’s recognised research strengths in the areas of molecular, cellular and developmental biology, bioinformatics and structural biology. These areas are complemented by Norway’s expertise in molecular mechanisms of disease, Sweden’s focus on microbial pathogenicity and molecular infection medicine as well as Finland’s strength in human genomics and medical systems biology. Furthermore, Denmark’s strength in neurobiology and structural biology will play an important role in the future. Altogether, this equips the partners to tackle some of the most challenging problems of biomedicine.

The Partnership provides access to scientific infrastructure, including databases, facilities and instrumentation, as well as to clinical materials and networks. Furthermore, the partners all adopt the EMBL model for international recruitment, training, staff turnover and scientific reviews.

Fakta om prosjektet

Project number: 68906

Prosjektleder

Kjetil Tasken, Universitetet i Oslo

Varighet
2014-2017